Pietro Picconi - Publications

Affiliations: 
2013-2018 King's College London, London, UK 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Picconi P, Hind CK, Sutton JM, Rahman KM. Covalent DNA Binding Is Essential for Gram-Negative Antibacterial Activity of Broad Spectrum Pyrrolobenzodiazepines. Antibiotics (Basel, Switzerland). 11. PMID 36551427 DOI: 10.3390/antibiotics11121770  0.731
2020 Picconi P, Hind C, Nahar KS, Jamshidi S, Di Maggio L, Saeed N, Evans B, Solomons J, Wand ME, Sutton JM, Rahman KM. New broad-spectrum antibiotics containing a pyrrolobenzodiazepine ring with activity against multidrug resistant Gram-negative bacteria. Journal of Medicinal Chemistry. PMID 32515951 DOI: 10.1021/acs.jmedchem.0c00328  0.81
2020 Vandera KA, Picconi P, Valero M, González-Gaitano G, Woods A, Clifton LA, Skoda MWA, Rahman KM, Harvey RD, Dreiss CA. Antibiotic-in-cyclodextrin-in-liposomes: formulation development and interactions with model bacterial membranes. Molecular Pharmaceutics. PMID 32352791 DOI: 10.1021/acs.molpharmaceut.0c00096  0.637
2019 Picconi P, Jeeves R, Moon CW, Jamshidi S, Nahar KS, Laws M, Bacon J, Rahman KM. Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against . Acs Omega. 4: 20873-20881. PMID 31867477 DOI: 10.1021/acsomega.9b00834  0.773
2018 Thurston D, Corcoran D, Picconi P, Chui C, Procopiou G, Pysz I, Rahman K. Formation of a Novel C11-Acetone Adduct of a Pyrrolobenzodiazepine (PBD) with Loss of Cytotoxicity Synlett. 29: 1112-1116. DOI: 10.1055/S-0036-1591552  0.592
2017 Andriollo P, Hind C, Picconi P, Nahar KS, Jamshidi S, Varsha A, Clifford M, Sutton JM, Rahman KM. C8-linked pyrrolobenzodiazepine monomers with inverted building blocks show selective activity against MDR Gram-positive bacteria. Acs Infectious Diseases. PMID 29260545 DOI: 10.1021/acsinfecdis.7b00130  0.744
2017 Picconi P, Hind C, Jamshidi S, Nahar K, Clifford M, Wand ME, Sutton JM, Rahman KM. Triaryl benzimidazoles as a new class of antibacterial agents against resistant pathogenic microorganisms. Journal of Medicinal Chemistry. PMID 28650661 DOI: 10.1021/acs.jmedchem.7b00108  0.837
2017 Picconi P, Prabaharan P, Auer JL, Sandiford S, Cascio F, Chowdhury M, Hind C, Wand ME, Sutton JM, Rahman KM. Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species. Bioorganic & Medicinal Chemistry. PMID 28600080 DOI: 10.1016/j.bmc.2017.05.037  0.737
2015 Rossi D, Talman V, Gennäs GBA, Marra A, Picconi P, Nasti R, Serra M, Ann J, Amadio M, Pascale A, Tuominen RK, Yli-Kauhaluoma J, Lee J, Collina S. Beyond the affinity for protein kinase C: exploring 2-phenyl-3-hydroxypropyl pivalate analogues as C1 domain-targeting ligands Medchemcomm. 6: 547-554. DOI: 10.1039/C4Md00564C  0.351
Show low-probability matches.